Skip to main content
OpenTrials

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 464 recruiting studies
Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Completed

A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma

NCT03006926

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • California Pacific Medical Center (CPMC) San Francisco, California, United States
  • Ronald Reagan UCLA Medical Center Santa Monica, California, United States
  • Mercy Medical Center Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Completed

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

NCT01421524

Conditions
Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +35 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • UCLA Neuro-Oncology Program Los Angeles, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States
  • University Of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 39 locations
View Trial Details
Completed

A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer

NCT00355238

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • City Of Hope National Medical Center Duarte, California, United States
  • City Of Hope National Medical Center Duarte, California, United States
  • Harbor UCLA Medical Center Los Angeles, California, United States
  • Harbor-Ucla Medical Center Los Angeles, California, United States
View all 37 locations
View Trial Details
Completed

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

NCT03684811

Conditions
Adenocarcinoma, Astrocytoma, Bile Duct Diseases, +25 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Northwestern University, Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 26 locations
View Trial Details

Related conditions